Elevation of insulin-like growth factor-binding protein-1 mRNA expression following hormone replacement therapy

Human Reproduction

Volumn 15, Issue 1, 2000, Pages 50-54

  Wang, Hsin Shih ^a   Wang, Tzu Hao ^a   Soong, Yung Kuei ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Endometrium; Hormone replacement therapy; IGF; IGFBP 1; Progesterone

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR; FOLLITROPIN; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; PROGESTERONE; PROGESTERONE RECEPTOR; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; FOLLITROPIN BLOOD LEVEL; GENE EXPRESSION; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; POSTMENOPAUSE; PROGESTERONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERUS BLEEDING; UTERUS MYOMA;

EID: 0033982593     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.1.50     Document Type: Article

References (20)

1. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
2. Gao, J.G., Zhu, H.H., Fan, J. et al. (1995) Progestin and antiprogestin differentially regulate the expression of insulin-like growth factors (IGF-I and IGF-II) messenger ribonucleic acid in human endometrial stromal cells. Biol. Reprod., 53, 355-360.
3. Giudice, L.C., Dsupin, B.A., Jin, I.H. et al (1993) Differential expression of messenger ribonucleic acids encoding insulin-like growth factors and their receptors in human uterine endometrium and decidua. J. Clin. Endocrinol. Metab., 76, 1115-1122.
4. Holly, J.M.P. and Wass, J.A.H. (1989) Insulin-like growth factors: automne, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments. J. Endocrinol., 122, 611-618.
5. Murphy, L.J. and Ghahary, A. (1990) Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation. Endocr. Rev., 11, 443-453.
6. Norrelund, H., Fisker, S., Vahl, N. et al. (1999) Evidence supporting a direct suppressive effect of growth hormone on serum IGFBP-1 levels. Experimental studies in normal, obese and GH-deficient adults. Growth Honn. IGF Res., 9, 52-60.
7. Pekonen, F., Nyman, T., Lahteenmaki, P. et al. (1992) Intrauterine progestin induces continuous insulin-like growth factor binding protein-1 production in the human endometrium. J. Clin. Endocrinol. Metab., 75, 660-664.
8. Rutanen, E.-M. and Pekonen, F. (1991) Insulin-like growth factor binding protein-1 in human endometrial function. In Spencer, E.M. (ed.), Modem Concepts of Insulin-like Growth Factors. Elsevier, New York, pp. 285-294.
9. Rutanen, E.-M., Salmi, A. and Nyman, T. (1997) mRNA expression of insulinlike growth factor-I (IGF-I) is suppressed and those of IGF-II and IGFbinding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel system. Mol. Hum. Reprod., 3, 749-754.
10. Suhonen, S., Haukkamaa, M., Holmstrom, T. et al. (1996) Endometrial response to hormone replacement therapy as assessed by expression of insulin-like growth factor-binding protein-1 in the endometrium. Fertil. Steril., 65, 776-782.
11. Suikkari, A.-M., Koivisto, V.A., Koistinen, R. et al. (1989) Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. J. Clin. Endocrinol. Metab., 68, 135-140.
12. Suvanto-Luukkonen, E., Sundstrom, H., Penttinen, J. et al. (1995) Insulinlike growth factor-binding protein-1: a biochemical marker of endometrial response to progestin during hormone replacement therapy. Maturitas, 22, 255-262.
13. Wang, H.S. and Chard, T. (1992) Chromatographie characterization of insulinlike growth factor-binding proteins in human pregnancy serum. J. Endocrinol., 133, 149-159.
14. Wang, H.S. and Chard, T. (1999) IGF and IGF-binding proteins in the regulation of human ovaries and endometrial function. J. Endocrinol., 161, 1-13.
15. Wang, H.S. and Soong, Y.K. (1996) Transvaginal progesterone supplementation increases serum insulin-like growth factor-binding protein-1 levels. Gynecol. Endocrinol., 10, 349-355.
16. Wang, H.S., Perry, L.A., Kanisius, J. et al. (1991) Purification and assay of insulin-like growth factor-binding protein-1: measurement of circulating levels throughout pregnancy. J. Endocrinol., 128, 161-168.
17. Wang, H.S., Lee, J.D. and Soong, YK. (1995) Serum levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 and -3 in women with regular menstrual cycles. Fertil. Steril., 63, 1204-1209.
18. Wood, A.J. (1994) Hormonal treatment of postmenopausal %vomen. N. Engl. J. Med., 330, 1062-1071.
19. Writing Group for the PEPI Trial (1995) Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA, 273, 199-208.
20. Zhou, J., Dsupin, B.A., Giudice, L.C. and Bondy, C.A. (1994) Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle. J. din. Endocrinol. Metab., 79, 1723-1734.